Efficient induction of apoptosis by wee1 kinase inhibition in hepatocellular carcinoma cells
Tomomi Kogiso1, Hikaru Nagahara2, Etsuko Hashimoto1
1Institute of Gastroenterology, Department of Internal Medicine, Tokyo Women's Medical University, Tokyo, Japan.
Abstract:
Transforming growth factor-β1 (TGF-β1) potently inhibits human hepatocellular carcinoma (HCC) cell growth. Here we demonstrated that TGF-β1-induced apoptosis is mediated by decreased phosphorylation of cdc2 at Tyr15 accompanied by down-regulation of Wee1 kinase expression. As expected from these results, a Wee1 kinase inhibitor efficiently induced apoptosis in HCC cells in the absence of TGF-β1 treatment. In surgically resected samples, Wee1 kinase was expressed in moderately to poorly differentiated HCC, whereas no Wee1 kinase expression was observed in non-cancerous tissue, including cirrhotic tissue. Our results suggest that Wee1 kinase inhibitors may be a practical novel therapeutic option against advanced HCC.
Insights
Transforming growth factor-β1 (TGF-β1) inhibits hepatocellular carcinoma (HCC) cell growth by reducing Wee1 kinase. Wee1 kinase inhibitors show promise for treating advanced HCC.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Transforming growth factor-β1 (TGF-β1) is a potent inhibitor of human hepatocellular carcinoma (HCC) cell proliferation.
- The precise molecular mechanisms underlying TGF-β1's anti-proliferative effects in HCC require further elucidation.
Purpose of the Study:
- To investigate the role of Wee1 kinase in TGF-β1-induced apoptosis of HCC cells.
- To evaluate the therapeutic potential of targeting Wee1 kinase in advanced HCC.
Main Methods:
- Investigated the effect of TGF-β1 on cdc2 phosphorylation and Wee1 kinase expression in HCC cells.
- Utilized a Wee1 kinase inhibitor to induce apoptosis in HCC cells.
- Analyzed Wee1 kinase expression in surgically resected HCC and non-cancerous tissues.
Main Results:
- TGF-β1 treatment led to decreased phosphorylation of cdc2 at Tyr15 and down-regulation of Wee1 kinase expression.
- A Wee1 kinase inhibitor effectively induced apoptosis in HCC cells, independent of TGF-β1.
- Wee1 kinase was significantly expressed in moderately to poorly differentiated HCC tissues but not in non-cancerous or cirrhotic tissues.
Conclusions:
- TGF-β1-induced apoptosis in HCC is mediated by the down-regulation of Wee1 kinase and subsequent decreased cdc2 phosphorylation.
- Wee1 kinase represents a potential therapeutic target for advanced HCC.
- Wee1 kinase inhibitors may offer a novel treatment strategy for advanced hepatocellular carcinoma.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
